Nobody Told Me Food Would Taste Different, and There Is a PCOS Trial About Exactly That

The thing I noticed in week three

Coffee tasted wrong.

Not bad — sharper. I could taste something bitter underneath it that I am fairly sure had always been there and that I had never once registered in fifteen years of drinking it. Salt got louder. A tomato tasted like an event.

I had been warned that I would not want food. Nobody warned me it would taste like a different food.

I assumed I was imagining it, the way you assume everything on a new drug is either imagination or catastrophe. Then I went looking, because I have PCOS and I have learned that if I do not go looking, nobody hands me anything.

There is a study, and it is about exactly this

Thirty women with PCOS, average age about 34, randomized to semaglutide or placebo for sixteen weeks. The researchers tested taste with strips soaked in four concentrations of the four basic tastes, took tongue biopsies for gene expression, and scanned brains with functional MRI while showing pictures of food¹.

Taste recognition scores went from 11.9 to 14.4 — an estimated treatment difference of 2.5 points, with a confidence interval of 1.7 to 3.3¹.

So I was not imagining it. My taste got measurably better, not worse.

The tongue biopsies found differences in the expression of genes tied to taste signaling, neural plasticity and the renewal of taste buds. The brain scans found reduced activation in the putamen — a region tied to reward — when the women were shown pictures of food¹.

I keep thinking about that combination. The tongue got sharper and the wanting got quieter. Which is a strange thing to be told is happening inside your own mouth, and a stranger one to only find out by looking it up.

The part that annoyed me

Every one of the PCOS trials I could find used semaglutide at 1.0 mg a week.

That is the diabetes dose. Wegovy, the version prescribed for weight, goes to 2.4 mg.

So when somebody tells me "the research on Wegovy for PCOS shows," what they are usually describing is research done at well under half the dose I am on. It might scale. It might not. Nobody has run it at 2.4 mg in women with PCOS, so nobody knows, and I would rather be told that than be handed a number with a brand name attached to it that the study never used.

While I am at it: PCOS is not an approved use for any of these drugs. Not Wegovy, not Zepbound. Every prescription for it is off-label, which is legal and common and not the same as approved.

What the weight trial found

The largest semaglutide-and-PCOS trial I found randomized 100 overweight or obese women diagnosed by the Rotterdam criteria to either metformin alone or metformin plus semaglutide 1 mg weekly, for sixteen weeks. Eighty finished².

The combination group lost 6.09 kg on average, against 2.25 kg on metformin alone, with bigger improvements in BMI, waist-to-hip ratio and testosterone².

Two things I want to be honest about, because they were not obvious to me at first. The comparison is against metformin, not against nothing — so this tells me semaglutide added something on top of a drug most of us are already taking, which is genuinely useful. And those standard deviations are wide. An average of 6 kg with a spread of 3.34 means some women in that group lost very little.

A broader meta-analysis of GLP-1 drugs in women with PCOS and obesity reaches the same general place⁴: they help with weight and with some hormonal measures, and the trials are small.

The one that explains my stomach

There is a detail I found buried in an older study that made more sense of my first month than anything my prescriber said.

In women with PCOS and obesity specifically, semaglutide delayed four-hour gastric emptying³.

I mention it because most of what you read says these drugs barely slow the stomach at all over time — and in the general obesity trials, that is roughly what was found. But this one looked at women with PCOS, and it found a delay. I do not know whether PCOS makes a difference or whether it is just a different measurement. Neither does anyone else yet.

What I know is that feeling full for four hours after a small lunch is a real thing that happened to me, and there is at least one study in women like me where it is on the page.

Where this leaves me

I am still taking it. My cycle has done something it has not done unprompted in years, which I am not going to over-interpret from a sample size of me.

But I would have liked someone to say: the evidence for this in PCOS is small, it is short, most of it is at a lower dose than yours, and it is not what the drug is approved for. That is not a reason to say no. It is just the truth, and I would rather start something with the truth than with a brochure.

And I would have liked someone to mention the coffee.